Lorena Mosso1, Alejandra Martínez1, María Paulina Rojas2, Gonzalo Latorre3, Paula Margozzini3, Trinidad Lyng1, Jorge Carvajal4, Claudia Campusano1, Eugenio Arteaga1, Laura Boucai5. 1. Departments of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, Chile. 2. Family Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. 3. Public Health, Pontificia Universidad Catolica de Chile, Santiago, Chile. 4. Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. 5. Department of Medicine, Division of Endocrinology, Memorial Sloan-Kettering Cancer Center, Weill Cornell University, New York, NY, USA.
Abstract
OBJECTIVE: Thyroid dysfunction and obesity during pregnancy have been associated with negative neonatal and obstetric outcomes. Thyroid hormone reference ranges have not been established for the pregnant Hispanic population. This study defines thyroid hormone reference ranges during early pregnancy in Chilean women and evaluates associations of body mass index (BMI) with thyroid function. DESIGN, PATIENTS, MEASUREMENTS: This is a prospective observational study of 720 healthy Chilean women attending their first prenatal consultation at an outpatient clinic. Thyroid function [TSH, Free T4, Total T4 and antithyroid peroxidase antibodies (TPOAb)] and BMI were assessed at 8·8 ± 2·4 weeks of gestational age. RESULTS: Median, 2·5th percentile (p2·5), and 97·5th percentile (p97·5) TSH values were higher, while median, p2·5, and p97·5 free T4 values were lower in obese patients compared with normal weight patients. Obesity was associated with a median TSH 16% higher (P = 0·035) and a median free T4 6·5% lower (P < 0·01) than values from patients with normal weight. BMI had a small, but statistically significant effect on TSH (P = 0·04) and free T4 (P < 0·01) when adjusted by maternal age, TPO antibodies, parity, sex of the newborn, gestational age and smoking. In all TPOAb (-) patients, median (p2·5-p.97·5) TSH was 1·96 mIU/l (0·11-5·96 mIU/l) and median (p2·5-p.97·5) free T4 was 14·54 pmol/l (11·1 - 19·02 pmol/l). Applying these reference limits, we found a prevalence of overt and subclinical hypothyroidism of 0·9% and 3·05% respectively. CONCLUSIONS: TSH distributes at higher values and free T4 at lower values in obese pregnant women compared to normal weight pregnant women. Thyroid hormone reference ranges derived from Chilean patients with negative TPOAb are different from the fixed internationally proposed reference ranges and may be used in the Hispanic population.
OBJECTIVE:Thyroid dysfunction and obesity during pregnancy have been associated with negative neonatal and obstetric outcomes. Thyroid hormone reference ranges have not been established for the pregnant Hispanic population. This study defines thyroid hormone reference ranges during early pregnancy in Chilean women and evaluates associations of body mass index (BMI) with thyroid function. DESIGN, PATIENTS, MEASUREMENTS: This is a prospective observational study of 720 healthy Chilean women attending their first prenatal consultation at an outpatient clinic. Thyroid function [TSH, Free T4, Total T4 and antithyroid peroxidase antibodies (TPOAb)] and BMI were assessed at 8·8 ± 2·4 weeks of gestational age. RESULTS: Median, 2·5th percentile (p2·5), and 97·5th percentile (p97·5) TSH values were higher, while median, p2·5, and p97·5 free T4 values were lower in obesepatients compared with normal weight patients. Obesity was associated with a median TSH 16% higher (P = 0·035) and a median free T4 6·5% lower (P < 0·01) than values from patients with normal weight. BMI had a small, but statistically significant effect on TSH (P = 0·04) and free T4 (P < 0·01) when adjusted by maternal age, TPO antibodies, parity, sex of the newborn, gestational age and smoking. In all TPOAb (-) patients, median (p2·5-p.97·5) TSH was 1·96 mIU/l (0·11-5·96 mIU/l) and median (p2·5-p.97·5) free T4 was 14·54 pmol/l (11·1 - 19·02 pmol/l). Applying these reference limits, we found a prevalence of overt and subclinical hypothyroidism of 0·9% and 3·05% respectively. CONCLUSIONS:TSH distributes at higher values and free T4 at lower values in obese pregnant women compared to normal weight pregnant women. Thyroid hormone reference ranges derived from Chilean patients with negative TPOAb are different from the fixed internationally proposed reference ranges and may be used in the Hispanic population.
Authors: Frank A Quinn; Gennady N Gridasov; Sergey A Vdovenko; Natalia A Krasnova; Nadezhda V Vodopianova; Marina A Epiphanova; Monika Schulten Journal: Clin Chem Lab Med Date: 2005 Impact factor: 3.694
Authors: Geralyn Lambert-Messerlian; Monica McClain; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter Bernstein; Mary E D'Alton Journal: Am J Obstet Gynecol Date: 2008-07 Impact factor: 8.661
Authors: Rt Stricker; M Echenard; R Eberhart; M-C Chevailler; V Perez; F A Quinn; Rn Stricker Journal: Eur J Endocrinol Date: 2007-10 Impact factor: 6.664
Authors: Elizabeth N Pearce; Emily Oken; Matthew W Gillman; Stephanie L Lee; Barbarajean Magnani; Deborah Platek; Lewis E Braverman Journal: Endocr Pract Date: 2008 Jan-Feb Impact factor: 3.443
Authors: Carmen Castillo; Nicole Lustig; Paula Margozzini; Andrea Gomez; María Paulina Rojas; Santiago Muzzo; Lorena Mosso Journal: Endocrinol Metab (Seoul) Date: 2018-12
Authors: Sebastián Gutiérrez-Vega; Axel Armella; Daniela Mennickent; Marco Loyola; Ambart Covarrubias; Bernel Ortega-Contreras; Carlos Escudero; Marcelo Gonzalez; Martín Alcalá; María Del Pilar Ramos; Marta Viana; Erica Castro; Andrea Leiva; Enrique Guzmán-Gutiérrez Journal: PLoS One Date: 2020-11-24 Impact factor: 3.240
Authors: Toby Candler; Noah J Kessler; Chathura J Gunasekara; Kate A Ward; Philip James; Eleonora Laritsky; Maria S Baker; Roger Dyer; Rajavel Elango; David Jeffries; Robert A Waterland; Sophie E Moore; Marian Ludgate; Andrew M Prentice; Matt J Silver Journal: Sci Adv Date: 2021-11-05 Impact factor: 14.136
Authors: Joris A J Osinga; Arash Derakhshan; Glenn E Palomaki; Ghalia Ashoor; Tuija Männistö; Spyridoula Maraka; Liangmiao Chen; Sofie Bliddal; Xuemian Lu; Peter N Taylor; Tanja G M Vrijkotte; Fang-Biao Tao; Suzanne J Brown; Farkhanda Ghafoor; Kris Poppe; Flora Veltri; Lida Chatzi; Bijay Vaidya; Maarten A C Broeren; Beverley M Shields; Sachiko Itoh; Lorena Mosso; Polina V Popova; Anna D Anopova; Reiko Kishi; Ashraf Aminorroaya; Maryam Kianpour; Abel López-Bermejo; Emily Oken; Amna Pirzada; Marina Vafeiadi; Wichor M Bramer; Eila Suvanto; Jun Yoshinaga; Kun Huang; Judit Bassols; Laura Boucai; Ulla Feldt-Rasmussen; Elena N Grineva; Elizabeth N Pearce; Erik K Alexander; Victor J M Pop; Scott M Nelson; John P Walsh; Robin P Peeters; Layal Chaker; Kypros H Nicolaides; Mary E D'Alton; Tim I M Korevaar Journal: J Clin Endocrinol Metab Date: 2022-09-28 Impact factor: 6.134